Anti-Synthetase Syndrome clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy
open to eligible people ages 18-65
RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy
at UC Irvine
Our lead scientists for Anti-Synthetase Syndrome research studies include Tahseen Mozaffar, MD.
Last updated: